🇺🇸 FDA
Patent

US 9062002

Substituted pyridine derivatives as FabI inhibitors

granted A61PA61P31/04

Quick answer

US patent 9062002 (Substituted pyridine derivatives as FabI inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P31/04